Search clinical trials for: Relapsing-Remitting Multiple Sclerosis,
Total 14263 results
-
McGill UniversityNovartisCompletedMultiple Sclerosis-Relapsing-RemittingCanada
-
CelgeneCompleted
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University College DublinCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisIreland
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
BiogenWithdrawn
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Novartis PharmaceuticalsWithdrawnMultiple Sclerosis (Relapsing Remitting)
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
Novartis PharmaceuticalsWithdrawnRelapsing-remitting Multiple Sclerosis
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
Bristol-Myers SquibbActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of Kansas Medical CenterNational Multiple Sclerosis SocietyCompleted
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
University of Illinois at Urbana-ChampaignCompletedMultiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedMultiple SclerosisRussian Federation, Ukraine, Czech Republic
-
SanofiCompletedMultiple SclerosisUnited States, France, Canada, Germany, Spain, Finland, Norway
-
University of RochesterForest LaboratoriesCompleted
-
Albert SaizInstituto de Salud Carlos IIITerminated
-
EMD SeronoCompleted12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.Multiple SclerosisUnited States, Canada, Germany, Italy, Spain, Sweden
-
Clinica Universidad de Navarra, Universidad de...H. Lundbeck A/STerminated
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedSecondary Progressive Multiple SclerosisGermany
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
University College, LondonNational Multiple Sclerosis SocietyCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University at BuffaloVolcano CorporationCompletedMultiple SclerosisUnited States
-
Institute for Neurodegenerative DisordersBiogenCompletedMultiple SclerosisUnited States
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
University Hospital, ToulouseFrench Association for Research on Multiple SclerosisUnknown
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
AvigenTerminatedMuscle SpasticityCzech Republic, Ukraine, Germany, Russian Federation, Serbia
-
NovartisCompletedClinically Isolated Syndrome | Relapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceCompletedHealthy | Clinically Isolated Syndrome | Multiple Sclerosis (MS) | Radiologically Isolated Syndrome | Multiple Sclerosis (MS) Relapsing Remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveMonaco
-
Instituto de Investigación Sanitaria de la Fundación...Universidad Rey Juan CarlosCompletedUrinary Incontinence | Relapsing-Remitting Multiple SclerosisSpain
-
LAPIX Therapeutics Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Tiziana Life Sciences LTDWithdrawnMultiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis
-
Boston Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingIntellectual Disability | Tuberous Sclerosis | Autism DisorderUnited States
-
GAAD Medical Research Institute Inc.UnknownMultiple SclerosisCanada
-
Bristol-Myers SquibbRecruitingRelapsing-remitting Multiple Sclerosis (RRMS)Spain
-
CinnagenCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Iran, Islamic Republic of
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
Germans Trias i Pujol HospitalMinisterio de Sanidad, Servicios Sociales e IgualdadCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Spain
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Merck KGaA, Darmstadt, GermanySmerud Medical Research International AS; Merck Serono NorwayCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Norway
-
CelltrionRecruitingRelapsing-remitting Multiple SclerosisPoland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany